A New Approach to Treating Alzheimer's Disease Receives Major NIA Backing
T3D Therapeutics to Receive $9 Million Multiyear National Institute on Aging Grant for Phase 2 PIONEER Study in Mild-to-Moderate Alzheimer's Disease Patients
RESEARCH ... Lees verder